SS
PACB icon

Sunbelt Securities’s Pacific Biosciences PACB Stock Holding History

Sunbelt Securities’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16 Buy
+12
New +$21 ﹤0.01% 2895

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Sunbelt Securities's PACB Position: Q1 2026 in Review

Sunbelt Securities opened a new position in Pacific Biosciences (PACB) in Q1 2026: 12 shares worth $16. The stake represents ﹤0.01% of the portfolio and ranks #2895 among its holdings.

231 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

  • Sunbelt Securities held 12 shares of Pacific Biosciences worth $16 as of Q1 2026.
  • Pacific Biosciences was a new Sunbelt Securities position in Q1 2026.
  • Pacific Biosciences made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2895 holding.
  • 231 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.